Copyright Reports & Markets. All rights reserved.

Global Hypertension Drugs Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Hypertension Drugs Market Overview

      • 1.1 Product Overview and Scope of Hypertension Drugs
      • 1.2 Hypertension Drugs Segment by Type
        • 1.2.1 Global Hypertension Drugs Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Calcium Channel Blockers
        • 1.2.3 Diuretics
        • 1.2.4 Beta Blockers Vasodilators
        • 1.2.5 Angiotensin Converting Enzyme Inhibitors
        • 1.2.6 Alpha Blockers
        • 1.2.7 Angiotensin Receptor Blockers
        • 1.2.8 Renin Inhibitors
      • 1.3 Hypertension Drugs Segment by Application
        • 1.3.1 Hypertension Drugs Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospitals
        • 1.3.3 Clinics
        • 1.3.4 Others
      • 1.4 Global Hypertension Drugs Market by Region
        • 1.4.1 Global Hypertension Drugs Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Hypertension Drugs Market Size
        • 1.5.1 Global Hypertension Drugs Revenue (2014-2025)
        • 1.5.2 Global Hypertension Drugs Production (2014-2025)

      2 Global Hypertension Drugs Market Competition by Manufacturers

      • 2.1 Global Hypertension Drugs Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Hypertension Drugs Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Hypertension Drugs Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Hypertension Drugs Production Sites, Area Served, Product Types
      • 2.5 Hypertension Drugs Market Competitive Situation and Trends
        • 2.5.1 Hypertension Drugs Market Concentration Rate
        • 2.5.2 Hypertension Drugs Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Hypertension Drugs Production Market Share by Regions

      • 3.1 Global Hypertension Drugs Production Market Share by Regions
      • 3.2 Global Hypertension Drugs Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Hypertension Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Hypertension Drugs Production
        • 3.4.1 North America Hypertension Drugs Production Growth Rate (2014-2019)
        • 3.4.2 North America Hypertension Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Hypertension Drugs Production
        • 3.5.1 Europe Hypertension Drugs Production Growth Rate (2014-2019)
        • 3.5.2 Europe Hypertension Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Hypertension Drugs Production (2014-2019)
        • 3.6.1 China Hypertension Drugs Production Growth Rate (2014-2019)
        • 3.6.2 China Hypertension Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Hypertension Drugs Production (2014-2019)
        • 3.7.1 Japan Hypertension Drugs Production Growth Rate (2014-2019)
        • 3.7.2 Japan Hypertension Drugs Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Hypertension Drugs Consumption by Regions

      • 4.1 Global Hypertension Drugs Consumption by Regions
      • 4.2 North America Hypertension Drugs Consumption (2014-2019)
      • 4.3 Europe Hypertension Drugs Consumption (2014-2019)
      • 4.4 China Hypertension Drugs Consumption (2014-2019)
      • 4.5 Japan Hypertension Drugs Consumption (2014-2019)

      5 Global Hypertension Drugs Production, Revenue, Price Trend by Type

      • 5.1 Global Hypertension Drugs Production Market Share by Type (2014-2019)
      • 5.2 Global Hypertension Drugs Revenue Market Share by Type (2014-2019)
      • 5.3 Global Hypertension Drugs Price by Type (2014-2019)
      • 5.4 Global Hypertension Drugs Production Growth by Type (2014-2019)

      6 Global Hypertension Drugs Market Analysis by Applications

      • 6.1 Global Hypertension Drugs Consumption Market Share by Application (2014-2019)
      • 6.2 Global Hypertension Drugs Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Hypertension Drugs Business

      • 7.1 Novartis
        • 7.1.1 Novartis Hypertension Drugs Production Sites and Area Served
        • 7.1.2 Hypertension Drugs Product Introduction, Application and Specification
        • 7.1.3 Novartis Hypertension Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Daiichi Sankyo
        • 7.2.1 Daiichi Sankyo Hypertension Drugs Production Sites and Area Served
        • 7.2.2 Hypertension Drugs Product Introduction, Application and Specification
        • 7.2.3 Daiichi Sankyo Hypertension Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Actelion Pharmaceuticals
        • 7.3.1 Actelion Pharmaceuticals Hypertension Drugs Production Sites and Area Served
        • 7.3.2 Hypertension Drugs Product Introduction, Application and Specification
        • 7.3.3 Actelion Pharmaceuticals Hypertension Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Boehringer Ingelheim
        • 7.4.1 Boehringer Ingelheim Hypertension Drugs Production Sites and Area Served
        • 7.4.2 Hypertension Drugs Product Introduction, Application and Specification
        • 7.4.3 Boehringer Ingelheim Hypertension Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Pfizer
        • 7.5.1 Pfizer Hypertension Drugs Production Sites and Area Served
        • 7.5.2 Hypertension Drugs Product Introduction, Application and Specification
        • 7.5.3 Pfizer Hypertension Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served

      8 Hypertension Drugs Manufacturing Cost Analysis

      • 8.1 Hypertension Drugs Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Hypertension Drugs
      • 8.4 Hypertension Drugs Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Hypertension Drugs Distributors List
      • 9.3 Hypertension Drugs Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Hypertension Drugs Market Forecast

      • 11.1 Global Hypertension Drugs Production, Revenue Forecast
        • 11.1.1 Global Hypertension Drugs Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Hypertension Drugs Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Hypertension Drugs Price and Trend Forecast (2019-2025)
      • 11.2 Global Hypertension Drugs Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Hypertension Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Hypertension Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Hypertension Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Hypertension Drugs Production, Revenue Forecast (2019-2025)
      • 11.3 Global Hypertension Drugs Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Hypertension Drugs Consumption Forecast (2019-2025)
        • 11.3.2 Europe Hypertension Drugs Consumption Forecast (2019-2025)
        • 11.3.3 China Hypertension Drugs Consumption Forecast (2019-2025)
        • 11.3.4 Japan Hypertension Drugs Consumption Forecast (2019-2025)
      • 11.4 Global Hypertension Drugs Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Hypertension Drugs Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The standard definition of high blood pressure is determined by the Joint National Committee (JNC) on Detection, Evaluation, and Diagnosis of High Blood Pressure. A person is considered to have high blood pressure after three to six elevated blood pressure measurements over several months. These definitions apply to adults who are healthy and not using medication for high blood pressure. If the two pressures fall in different categories, the higher one is used to determine the severity of hypertension.
        With an increase in the population of older people, the market for hypertension drugs has a positive outlook over the forecast period. The prevalence of hypertension is high among the older population with close to 70% of the patients with high BP above the age of 60. Currently, close to 11% of the global population is aged 60 years or over and is estimated to reach nearly 22% by 2050. Since the risk of developing pulmonary hypertension increases with age, a growing older population will aid in the growth prospects of the hypertension drugs market in the coming years. 
        In 2015, the Americas was the largest market for hypertension drugs as it accounted for more than 44% of the market share. The US is the major revenue contributor in the region. The market share is declining due to the patent expiries of drugs such as Micardis, Avapro, and Diovan. However, comorbid conditions among the older population like congenital heart disease and increasing focus on combination therapies will prevent the decline in the market. Moreover, the launch of new disease-modifying therapies is expected to bolster the growth prospects of the market during the forecast period.

        The global Hypertension Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Hypertension Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hypertension Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Novartis
        Daiichi Sankyo
        Actelion Pharmaceuticals
        Boehringer Ingelheim
        Pfizer
        ...

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Calcium Channel Blockers
        Diuretics
        Beta Blockers Vasodilators
        Angiotensin Converting Enzyme Inhibitors
        Alpha Blockers
        Angiotensin Receptor Blockers
        Renin Inhibitors

        Segment by Application
        Hospitals
        Clinics
        Others

        Buy now